N-Nitroso Oxetacaine Stage D | N-methyl-N-(2-methyl-1-phenylpropan-2-yl)nitrous amide
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.N-Nitroso Oxetacaine Stage D can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nitrosamines .N-Nitroso Oxetacaine Stage D is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Oxetacaine Stage D CAS NO: NA Chemically represented as N-methyl-N-(2-methyl-1-phenylpropan-2-yl)nitrous amide.Synchemia is the leading manufacturing and exporter of N-Nitroso Oxetacaine Stage D .We supply N-Nitroso Oxetacaine Stage D with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142274 |
| CAS No | NA |
| Mol.F. | C4H9ClN2O |
| Mol.Wt. | 136.58 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142275 |
| CAS No | NA |
| Mol.F. | C23H24I2N2O5 |
| Mol.Wt. | 662.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142276 |
| CAS No | NA |
| Mol.F. | C23H22I2N2O5 |
| Mol.Wt. | 660.25 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142277 |
| CAS No | NA |
| Mol.F. | C25H30N2O4 |
| Mol.Wt. | 422.53 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142278 |
| CAS No | NA |
| Mol.F. | C15H22N4O5S |
| Mol.Wt. | 370 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142279 |
| CAS No | NA |
| Mol.F. | C5H11N3O |
| Mol.Wt. | 129.16 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142280 |
| CAS No | NA |
| Mol.F. | C14H20N4O5S |
| Mol.Wt. | 356.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142281 |
| CAS No | NA |
| Mol.F. | C13H17IN4O3 |
| Mol.Wt. | 404.21 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142282 |
| CAS No | NA |
| Mol.F. | C16H24N4O5S |
| Mol.Wt. | 384.45 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142283 |
| CAS No | NA |
| Mol.F. | C14H20IN3O2 |
| Mol.Wt. | 389.24 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142284 |
| CAS No | NA |
| Mol.F. | C16H23N3O5S |
| Mol.Wt. | 369.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142285 |
| CAS No | NA |
| Mol.F. | C10H13N3O |
| Mol.Wt. | 191.23 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142286 |
| CAS No | NA |
| Mol.F. | C17H19N3O |
| Mol.Wt. | 281.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142287 |
| CAS No | NA |
| Mol.F. | C14H22N4O3 |
| Mol.Wt. | 294.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142288 |
| CAS No | NA |
| Mol.F. | C15H10ClN3O2 |
| Mol.Wt. | 299.71 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142289 |
| CAS No | NA |
| Mol.F. | C11H15N3O3 |
| Mol.Wt. | 237.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |